It has been suggested that dichloromethane (DCM) and 1,2-dichloropropane (DCP) are responsible for occupational cholangiocarcinoma. Dihaloalkanes are metabolically activated by GSH S-transferase theta1 (GSTT1) to yield products such as episulfonium ions. However, whether the GSTT1-mediated step of these dihaloalkanes is related to occupational cholangiocarcinoma is not known. In the present study, we investigated the influence of GSTT1 activation on the mutagenicity of DCM and 1,2-DCP using
Introduction
Haloalkanes, such as dichloromethane (DCM) and 1,2-dichloropropane (1,2-DCP), are widely used as industrial solvents, and recent reports have suggested that DCM and 1,2-DCP may be responsible for the frequent occurrence of cholangiocarcinoma in the printing industry (1) (2) (3) (4) (5) . We previously reported the accumulation of large numbers of single nucleotide variants in exons of cholangiocarcinomas from workers at offset colour proof-printing companies (6) . Among these variants, the C:G to T:A transition with strandbias was predominant and mostly occurred at unique trinucleotide sequences, such as GpCpY and NpCpY. We also demonstrated the mutagenicity of DCM and 1,2-DCP using Ames Salmonella assays (6) . Notably, the three letter mutational patterns observed in the 1,2-DCP-treated Salmonella strains partially corresponded to those of the printing workers' cholangiocarcinomas. These results suggested that 1,2-DCP might contribute to the carcinogenesis of cholangiocarcinoma among printing industry workers, at least in part. However, the mechanisms for cholangiocarcinoma induced by 1,2-DCP have remained unknown.
Dihaloalkanes, such as DCM and dibromomethane, are metabolically activated by glutathione (GSH) S-transferase (GSTT1) to yield products such as episulfonium ions, which then react with DNA to form DNA-alkyl-GSH adducts (7) (8) (9) (10) . Previous studies showed that DCM induced only C:G to T:A transitions in S. typhimurium RSJ 100, a derivative of the TA1535 strain that expresses rat GSTT-1-1, and S-[1-(N 2 -deoxyguanosinyl)methyl]GSH (N 2 -GSH-Me-dG) or S- [1-(N 4 -deoxycytidinyl)methyl]GSH (N 4 -GSH-Me-dC) formation was suggested to be involved in these mutations (11) . In contrast to DCM, there are no reports regarding metabolic activation pathway of 1,2-DCP, and therefore whether GSTT1 is involved in its mutagenicity has not been determined. Moreover, whether the GSTT1-mediated step of these dihaloalkanes is involved in the development of occupational cholangiocarcinoma is not known. In the present study, we investigated the role of human GSTT1 on the mutagenicity of DCM and 1,2-DCP. Possible mechanisms for the genotoxicty induced by DCM and 1,2-DCP are also discussed.
Materials and methods
Chemicals DCM (>99.5% pure) and 1,2-DCP (>98.0% pure) were purchased from Nacalai Tesque, Inc. (Kyoto, Japan) and Wako Pure Chemical Industries, Ltd (Tokyo, Japan), respectively. We purchased 2'-deoxyribonucleosides, bovine spleen phosphodiesterase II and HPLC grade acetonitrile from Wako Pure Chemical Industries, Ltd (Osaka, Japan). Calf thymus DNA, DNase II from porcine spleen and acid phosphatase from potato were purchased from Sigma-Aldrich Co. LLC (St. Louis, MO, USA). DifcoTM Nutrient Broth and Cofactor-I was purchased from Becton, Dickinson and Company (Sparks, MD, USA) and Oriental Yeast Co., Ltd (Tokyo, Japan), respectively.
Expression of GSTT1 in Salmonella strain TA100
Salmonella typhimurium TA100 strains were used as host strains for the expression of human GSTT1. The beta-lactamase gene (Amp r ) in the bacterial expression vector pFLAG-CTC (Sigma-Aldrich, St. Louis, MO) was replaced with a kanamycin-resistance gene (pCTC-Km). The DNA fragment corresponding to the open reading frame of human GSTT1 mRNA was amplified from HepG2 cDNA by PCR. Primers used for PCR were as follows: GSTT1fHdIII, 5′-CACTATGAAGCTTGAGCTGTACCTGG-3′ and hGSTT1rSal, 5′-TATTAGTCGACTACCGGATCATGGCCAGCACCCAG-3′. The amplified cDNA was digested and inserted into the pCTC-Km vector using HindIII and SalI restriction enzymes. The plasmid was transformed first into the S. typhimurium LB5000 strain that lacks three restriction systems, which was kindly provided by Dr M. Yamada (Division of Genetics and Mutagenesis, National Institute of Health Sciences, Japan). The modified plasmid was then reintroduced into the S. typhimurium TA100 strain (TA100-GST). The empty vector was also reintroduced into the TA100 strain (TA100-pCTC) and used as a mock control.
For induction of GSTT1, TA100-GST was cultured overnight in LB broth containing ampicillin (25 μg/mL), kanamycin (25 μg/mL) and isopropyl β-D-1-thiogalactopyranoside (IPTG, 100 mM). To confirm the expression of GSTT1, GSTT1 activity towards DCM was measured by the formaldehyde colorimetric method (Hantzsch reaction) described previously (12) . Formaldehyde production was clearly observed in TA100-GST after induction of IPTG (data not shown).
Mutagenicity assay
The mutagenicity assays of 1,2-DCP and DCM in S. typhimurium TA100-pCTC and TA100-GST strains in the absence of a metabolic activation system were used as described previously (6) . In brief, appropriately sized filter papers that absorbed multiple doses of 1,2-DCP or DCM were placed into plastic bags. Uncovered plates with cultured bacteria were then placed into the plastic bags and bags were sealed tightly. To accelerate the GSTT1 reaction, GSH solution (20 mM Hepes, 5 mM GSH, pH 7.4) was added to the agar in the plates. The chemical vapour concentrations in the plastic bags were calculated with calibration curves analysed by gas chromatography mass spectrometry analysis as described previously (6) . After 2 h of vapour exposure at 37°C, the plates were removed from the bags and incubated for another 48 h. The hisG+ revertant colonies were counted for evaluation of mutagenicity. Mutagenic activities of the samples were calculated from the linear portions of the doseresponse curves, which were obtained with three doses in duplicate plates in at least two independent experiments.
Sequencing of hisG46 mutations
Colonies obtained from the highest concentration of DCM (3500 ppm) and 1,2-DCP (3000 ppm) exposure were used for mutational spectrum analyses. Mutagenicity was approximately 2-fold higher than background for DCM-exposed TA100-pCTC, 1,2-DCP-exposed TA100-pCTC and TA100-GST, and approximately 6-fold higher than background for DCM-exposed TA100-GST. A 201 bp DNA fragment containing the hisG46 site was amplified by colony PCR (forward primer: 5′-GAT TGA TAT CCT GCG CGT GCG TG-3′ and reverse primer: 5′-TCG TCA ACC GGT GTT GCC AGC G-3′). Sequence analysis was performed at Takara Bio Inc. (Mie, Japan).
Chemical synthesis of S-
First, S-(acetoxymethyl)glutathione (GSCH 2 OAc) was synthesized according to the previously reported procedure (9) . Synthesized GSCH 2 OAc was stored dessicated at −80°C and used without further purification. The 2'-deoxyguanosine (dG) and 2'-deoxicytidine (dC) adducts were synthesized by reacting of dG (3 mg), dC (3 mg) or calf thymus DNA (1 μg) with GSCH 2 OAc (10 mg) in 2 mL of milliQ water for deoxyribonucleosides or 50 mM sodium acetate buffer (pH 5.3) for calf thymus DNA. The reaction was incubated at 37°C for 1 h, and the reaction was terminated by adding 0.4 mL of 3 M NH 4 CH 3 CO 2 . Synthesized GSH-Me-DNA adducts derived from deoxyribonucleosides were used as authentic adducts without further purification. Adduct samples formed from calf thymus DNA were necessary to digest with various nucleases described below before analysis of GSH-Me-DNA.
Analysis of DNA adducts
For DNA adduct analyses, TA100-pCTC or TA100-GST strains were first cultured in nutrient broth media overnight, and then cultured on nutrient broth plates containing ampicillin (25 μg/mL) and IPTG (100 mM) for 24 h at 37°C. DCM vapour exposure was performed as described above. After chemical exposure, bacteria were harvested and DNA was extracted by standard procedures involving enzymatic digestion of protein and RNA, followed by extraction with phenol and chloroform/isoamyl alcohol (24:1, v/v). DNA samples were then enzymatically digested according to the previously described procedure (9) . The enzymatic digestion conditions were as follows: DNA (50 μg) in sodium acetate buffer (pH 5.3, final 60 mM) containing MgSO 4 (final 40 mM) and NaCl (final 100 mM) in DNase II (from porcine spleen) for 30 min. Phosphodiesterase II (from bovine spleen) was then added, and samples were incubated for a further 30 min at 37°C. Acid phosphatase (from potato) was added for an additional 2 h at 37°C. The sample was purified using Vivacon500 ® (10 kDa molecular weight cut-off filters, Sartorius AG, Goettingen, Germany), and the reaction mixture was centrifuged (4°C, 10 000 × g, 15 min) using Ultrafree ® (0.2 μm pore; Millipore Co. MA, USA). The filtrate was subjected to liquid chromatography tandem mass spectrometry (LC/MS/MS) for DNA adduct analysis. LC/MS/MS analyses were performed using a Waters 2795 LC system (Waters, Manchester, UK) interfaced with a Quattro Ultima triple stage quadrupole MS (Waters). The LC column was eluted over a gradient that began at a ratio of 2% acetonitrile to 95% in 10 mM ammonium acetate (pH 4.0), changed to 30% acetonitrile over a period of 40 min, maintained at 30% acetonitrile from 40 to 45 min, then changed to 95% acetonitrile from 45 to 49 min. Sample injection volumes of 20 μL each were separated on a Shim-pack FC-ODS column (150 × 2.0 mm, 3 μm, Shimadzu, Kyoto, Japan) and eluted at a flow rate of 0.2 mL/min. Mass spectral analyses were carried out in positive ion mode with nitrogen as the nebulizing gas. The ion source temperature was 120°C; the desolvation gas temperature was 350°C. Nitrogen gas was also used as the desolvation gas (660 L/h) and cone gas (35 L/h), and argon was used to provide a collision cell pressure of 1. 
Results

Mutagenic activity of 1,2-DCP and DCM in Salmonella strains
Mutagenic activities of 1,2-DCP and DCM were examined using TA100-pCTC and TA100-GST strains without metabolic activation systems. As shown in Figure 1 , both haloalkanes showed mutagenicity in these Salmonella strains in a dose-dependent manner. The mutagenic activities of 1,2-DCP and DCM against TA100-pCTC were 11.3 ± 1.7 revertants/100 ppm and 4.5 ± 1.4 revertants/100 ppm, respectively. These results indicated that the mutagenic potency of 1,2-DCP was higher than that of DCM. In the human GSTT1-expressing strain, TA100-GST, DCM exposure showed high mutagenic activity, almost 8-fold higher relative to the mock control TA100-pCTC (Figure 1b) . In contrast, the mutagenicity of 1,2-DCP was almost comparable between both TA100-GST and TA100-pCTC strains (Figure 1a) .
We next analysed reverse mutations occurring at the hisG46 site of both strains with DCM-or 1,2-DCP-exposure by DNA sequencing (Figure 2 ). In the case of 1,2-DCP-exposure, C:G to T:A transitions were predominant in both TA100-pCTC and TA100-GSTT1 strains. We also found that C:G to T:A transitions were also increased in both strains compared to the background spontaneous mutation spectrum; however, the trinucleotide pattern of CCC to CTC was dramatically increased in TA100-pCTC, although CCC to TCC was slightly increased in TA100-GST. On the other hand, in response to DCM exposure, C:G to G:C transversions were increased in TA100-pCTC compared to controls, while C:G to T:A transitions, especially the trinucleotide pattern of CCC to CTC, were dramatically increased in the TA100-GSTT1 strain (Figure 2b ).
Analysis of GSH-Me-DNA adducts in Salmonella strains
To confirm the formation of DNA adducts derived from DCM, we first synthesized N 2 -GSH-Me-dG and N 4 -GSH-Me-dC as previously described (9) . were eluted at the same retention time for 24.84. Formation of GSHMe-DNA adducts also analysed using calf thymus DNA instead of deoxyribonucleosides. Both N 2 -GSH-Me-dG and N 4 -GSH-Me-dC could be detected, however the yield of N 4 -GSH-Me-dC was almost 150-fold lower than that of N 2 -GSH-Me-dG (data not shown). When the GSH-Me-DNA adducts were analysed using TA100-pCTC and TA100-GSH after exposure to DCM, N 2 -GSH-Me-dG was detected in both strains. However, N 4 -GSH-Me-dC was detected in either Salmonella strain under the same conditions used in the present study. Figure 4 shows LC-ESI-MS/MS analysis of the N 2 -GSH-Me-dG in TA100-pCTC after exposure of DCM. Two peaks with m/z (M+H) 587.2 → 471.2 and 587.2 → 308.2 corresponding to N 2 -GSH-Me-dG, eluted at same retention times, were observed in the DNA digestion obtained from DCM-exposed TA100-pCTC. In the case of TA100-GSH, N 2 -GSH-Me-dG was also detected at high amounts. The adduct level was calculated as dG equivalent, tentatively, and values were 1.03 ± 0.32 per 10 8 nucleotides for TA100-pCTC and 12.22 ± 5.32 per 10 8 nucleotides for TA100-GST.
Discussion
Our previous data using Salmonella typhimurium TA100 suggested that 1,2-DCP and DCM possibly induce mutations in C:G residues of genomic DNA (6) . In the present study, the mutagenic activity of DCM was markedly increased in TA100-GST, which expresses human GSTT1, compared with TA100-pCTC. The mutation spectrum analysis at the his G46 site revealed that the C:G to T:A mutation was markedly elevated in TA100-GST exposed to DCM. DeMarini et al. reported that the mutagenic potency of DCM was 35 revertants/100 ppm for the rat GSTT1-expressing strain RSJ100 and 4.1 revertants/100 ppm for the GSTT1-nonexpressing strain TA100. These values were comparable to those in the present study. Moreover, the majority of the mutation spectrum in the previous study was C:G to A:T, especially the CCC to CAC trinucleotide mutation pattern (11), which was also similar to results from the previous study. In general, haloalkanes, including DCM, are metabolized via a GSTT1-dependent pathway to produce potentially carcinogenic reactive intermediates, such as episulfonium ions (13, 14) . DeMarini et al. reported that S-(chloromethyl)glutathione is involved in mutagenesis to form a guanine adduct, N 2 -GSH-Me-dG, and might induce G to T and G to A substitutions in bacteria and mammalian cells (11, 15, 16) . Therefore, our findings were consistent with previously reported in vitro data. In fact, we identified N 2 -GSH-Me-dG in both TA100-pCTC and TA100-GSTT1 strains. Moreover, the production level of N 2 -GSH-Me-dG was increased in TA100-GSTT1. Interestingly, C:G to A:T and C:G to G:C were predominant in TA100-pCTC exposed to DCM; however, this almost completely switched to C:G to T:A in DCM-exposed TA100-GSTT1. This suggests that the DNA adduct responsible to induce mutation might be different in these two strains. Since an increase of N 2 -GSH-Me-dG was observed in DCM-exposed TA100-GSTT1, this DNA adduct might be involved in the C:G to T:A transition. However, the DNA adduct related to C:G to A:T and/or C:G to G:C in DCM-exposed TA100-pCTC is not known. Since formaldehyde is produced via the GSTT1-mediated DCM metabolic pathway (11), we cannot rule out that formaldehyde might be involved in these mutations induced by DCM exposure. In fact, several DNA adducts including cross-link and/or exocyclic adducts were produced in the reaction of formaldehyde and deoxyadenosine or dG (17) .
The metabolism pathways of 1,2-DCP have not yet been elucidated. Some reports postulate that episulfonium ions can also be produced from 1,2-DCP in a similar way to that from DCM (17, 18) . However, in the present study, the mutagenic activity induced by 1,2-DCP was not affected by human GSTT1 expression (Figure 2a ). This suggests that other mechanisms are probably involved in the mutagenesis of 1,2-DCP. Supporting our findings, Tornero-Velez et al. reported that 1,3-dichloropropane (1,3-DCP), Figure 2 . Mutation spectra for hisG46 reversions of TA100 derivative strains treated with dihaloalkanes. Point mutation profiles occurred at the hisG gene target site in TA100 derivative strains exposed to 1,2-DCP (a) and DCM (b). Control colonies were prepared by the same procedure described in Materials and Methods without any chemical exposure. The numbers of mutants analysed were as follows: 29 clones for control TA100-pCTC, 30 clones for 1,2-DCP-exposed TA100-pCTC, 31 clones for DCM-exposed TA100-pCTC, 44 clones for control TA100-GST, 44 clones for 1,2-DCP-exposed TA100-GST and 43 clones for DCM-exposed TA100-GST. a structural isomer of 1,2-DCP, demonstrated negative mutagenic activity toward the RSJ100 strain that expresses rat GSTT (19) . They also reported that S-(3-chrolopropyl)GSH, a sulfonium ion intermediate derived from 1,3-DCP, was detected in a reaction mixture of 1,3-DCP and mouse liver cytosol containing a GSTT1 fraction using LC-MS analysis. This means that S-(3-chrolopropyl)GSH is a stable conjugate, and thus is unlikely to interact in subsequent reactions with DNA (19) . In the same manner, GSTT1 would act as a detoxification pathway for 1,2-DCP and would not be involved in mutagenesis. Similarly, 1,3-dichloropropene (1,3-DCPe), a structural analog of 1,2-DCP, also did not show the increasing effect of GSTT1-1 enzyme on its mutagenicity in RSJ100, while 1,1-dichloropropene (1,1-DCPe) demonstrated more than a 500-fold increase of mutagenic potency in the rat GSTT1-1 expressing RSJ100 strain compared with the TPT100 strain that contains the GSTT1-1 gene in an inverted orientation and does not express this gene (20) . Both 1,1-DCPe and 1,3-DCPe yielded the stable monochloropropene S-conjugate isomers in the reaction mixture of GSH and mouse liver cytosol; however the reactive episulfonium ion was probably only yielded from 1,1-DCPe. It is also speculated that 1,3-DCPe is more likely to produce a stable epoxide by metabolic activation with P450s (20) . P450-dependent oxidation, especially for CYP2E1, is known as the primary metabolic pathway of haloalkanes (21) . Some reports have indicated that CYP2E1 is involved in hepatotoxicity of mice and hamster induced by 1,2-DCP (22, 23) . Gi et al. demonstrated that CYP2E1 was increased in the centrilobular area of the livers of hamsters treated with 1,2-DCP and these lesions corresponded to hepatocellular damaged areas observed in hamsters treated with 1,2-DCP (22). Yanagiba et al. also reported that pathological changes of the liver, such as necrosis, were observed in 1,2-DCP-treated wildtype mice but not in cyp2e1-null mice (23) . Therefore, oxidation of 1,2-DCP mediated by CYP2E1 might be the key pathway responsible for bioactivation and the hepatotoxicity.
Although oxidation of 1,2-DCP is considered to be required for appearance of toxicity, in the present study, mutagenicity of 1,2-DCP was observed in the absence of metabolic activation systems. In our preliminary study, mutagenic activity was also observed in S. typhimurium TA100 with S9 mix; however, the number of hisG + revertant colonies was decreased compared to the strain with absence of S9 mix (data not shown). This suggests that S9 functions in a detoxification role for 1,2-DCP, even though CYP2E1 probably existed in the S9 mix. In general, phenobarbital and 5,6-benzoflavone are used as inducers for P450 enzymes to prepare the S9 fraction. It is well known that phenobarbital and 5,6-benzoflavone are CYP1A1 and CYP1A2 inducers. Therefore it is probable that CYP1A1 and CYP1A2 are predominant and the amount of CYP2E1 is not enough to activate 1,2-DCP in the commercial base S9 fraction. On the other hand, mutagenicity of 1,2-DCP was observed in the S. typhimurium strains without addition of any metabolic activation systems. Many kinds of enzymes functioning in metabolic and biosynthesis systems exist in the bacteria; thus, many types of bacterial enzymes might be involved in the activation of 1,2-DCP in the present study. The mechanisms for the mutagenicity of 1,2-DCP are still not known and further study is required.
The mechanism underlying the development of occupational cholangiocarcinoma is thought to be a result of the preferential expression of GSTT1 in bile duct epithelial cells via a GSTT1-dependent pathway to produce potentially carcinogenic reactive intermediates, such as S-(chloromethyl)glutathione (24, 25) . This speculation would be supportive of DCM-mediated cholangiocarcinoma. On the other hand, we clearly demonstrated that GSTT1 is not responsible for the genotoxic effect of 1,2-DCP. This suggests that another mechanism plays a role in the occupational cholangiocarcinoma caused by 1,2-DCP. In our previous report, the cholangiocarcinomas in printing workers had characteristic trinucleotide mutational contexts, namely, NpCpY to NpTpY or NpApY changes with strong strand biases. Mutations with transcriptional strand bias are known to occur in DNA adducts in cancer genomes (26, 27) . Recently, it was reported that NpCpY (the complementary RpGpN) sites were the target of alkylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (26, 28) . Based on the similarity of the mutational context, alkyl DNA adducts would likely be produced from 1,2-DCP mediated by a CYP-metabolic activation pathway. No data are available regarding the chemical structures of 1,2-DCP-DNA adducts, except for the mutational spectral data for 1,2-DCP, and therefore, it is reasonable to conclude that the guanine base may be involved to form 1,2-DCP-DNA adducts. To understand the role of DCM/1,2-DCP in human carcinogenesis, studies on clarification of the mechanisms for DCM-and/or 1,2-DCP-related cholangiocarcinoma development is important to establish risk assessment and prevention. Moreover, the analysis of DCM-and/or 1,2-DCP-DNA adducts will also be required to evaluate the exposure levels for these chemicals.
Conclusion
Here we investigated the influence of GSTT1 activation on the mutagenicity of DCM and 1,2-DCP. We found that the mutagenicity of DCM was significantly increased in TA100-GST compared with the mock control. Moreover, the C:G to T:A transition was dramatically increased in DCM-exposed TA100-GST. We also demonstrated that formation of N 2 -GSH-Me-dG was increased in TA100-GST compared with TA100-pCTC. These findings suggest that GSTT1 is involved in the mutagenicity of DCM via formation of N 2 -GSH-Me-dG. On the other hand, 1,2-DCP did not increase the mutagenicity in TA100-GSTT1. This suggests that GSTT1 has little involvement in 1,2-DCP mutagenicity, and other mechanisms, such as oxidation, might be more important for bioactivation and consequent genotoxicity. Mutation spectrum Fig. 4 . Analysis of N 2 -GSH-Me-dG in TA100-pCTC after exposure to DCM. The sample was subjected to LC-ESI/MS with standard compounds, N 2 -GSH-Me-dG, synthesized by reactions between GSCH 2 OAc and calf thymus DNA. DNA samples containing authentic N 2 -GSH-Me-dG (upper) and obtained from DCM-exposed TA100-pCTC (lower) were enzymatically digested as described in Materials and Methods before application on the column. Conditions used for LC-MS were the same as for Figure 3. analysis revealed that the C:G to T:A transition in the hisG gene was predominant in both DCM (TA100-GST) and 1,2-DCP. Since the same mutation spectrum was observed in human cholangiocarcinoma genome data (6) , this suggests that these dihaloalkanes would be partly involved in human cancer development. The mechanism underlying the development of occupational cholangiocarcinoma, but not hepatocellular carcinoma, may be a result of the preferential expression of GSTT1 in bile duct epithelial cells rather than hepatocytes (24, 25) . This speculation would be supportive of DCM-mediated cholangiocarcinoma. On the other hand, we demonstrated that GSTT1 is not responsible for the genotoxic effect of 1,2-DCP. This suggests that another mechanism plays a role in the occupational cholangiocarcinoma caused by dihaloalkanes. Further investigation for clarification of the mechanisms for DCM-and/or 1,2-DCP-related human cholangiocarcinoma development is important to establish risk assessment and prevention. Moreover, future study on the formation of 1,2-DCP-DNA adduct will also be required to evaluate the exposure levels for these chemicals. 
